ANGIOTENSIN-CONVERTING ENZYME-INHIBITION AND BETA-ADRENOCEPTOR BLOCKADE REGRESS ESTABLISHED VENTRICULAR REMODELING IN A CANINE MODEL OF DISCRETE MYOCARDIAL DAMAGE
Km. Mcdonald et al., ANGIOTENSIN-CONVERTING ENZYME-INHIBITION AND BETA-ADRENOCEPTOR BLOCKADE REGRESS ESTABLISHED VENTRICULAR REMODELING IN A CANINE MODEL OF DISCRETE MYOCARDIAL DAMAGE, Journal of the American College of Cardiology, 24(7), 1994, pp. 1762-1768
Objectives. This study was designed to assess the effect of angiotensi
n converting enzyme inhibition and beta-adrenoreceptor blockade on est
ablished ventricular remodeling. Background. Angiotensin converting en
zyme inhibitor therapy attenuates the development of ventricular remod
eling when given shortly after myocardial infarction. However, regress
ion of established ventricular remodeling after infarction has receive
d little attention. Methods. The relative effects of angiotensin conve
rting enzyme inhibitor therapy and beta-adrenoceptor blockade on estab
lished ventricular remodeling were assessed in a canine model characte
rized by increased left ventricular mass and chamber dilation as a res
ult of localized myocardial necrosis produced by transmyocardial direc
t current shock Dogs were randomly assigned to 3 months of therapy wit
h captopril (25 mg twice daily, n = 7) or metoprolol (100 mg twice dai
ly, n = 7) or to a control group with no intervention (n = 6), 11 +/-
4 (mean +/- SD) months after acute myocardial damage. Results. Compare
d with the control group, dogs in both the captopril and metoprolol gr
oups had reduced left ventricular mass as measured by magnetic resonan
ce imaging (-8.1 +/- 3.8 vs. 1.7 +/- 2.8 g, p = 0.003 and -9.6 +/- 5.6
vs. 1.7 +/- 2.8 g, p = 0.001), respectively. Captopril and metoprolol
also produced a reduction in left ventricular end diastolic volume (-
7.6 +/- 6.0 and -6.0 +/- 5.8 ml, respectively) compared with the contr
ol value (-1.6 +/- 3.8 ml) (p = 0.14 [NS]). Both agents reduced mean a
rterial pressure but had disparate effects on pulmonary wedge pressure
and right atrial pressure. There was no significant correlation betwe
en change in ventricular mass or volume and change in any measured hem
odynamic or neurohormonal variable. Conclusions. These data suggest th
at pharmacologic intervention with angiotensin-converting enzyme inhib
ition or beta-adrenoceptor blockade can result in regression of establ
ished ventricular remodeling. The mechanism of this response will requ
ire further study, but these data did not support a close association
between regression of remodeling and hemodynamic unloading of the vent
ricle or systemic neuroendocrine factors.